McLean LP, Cross RK. Pharmacodynamic assessment of vedolizumab for the treatment of ulcerative colitis.
Expert Opin Drug Metab Toxicol. 2016; 1–10 DOI: 10.1080/17425255.2016.1181171
When the above article was first published online, permission details in tables 1, 2, 3 and 4 were incorrect. This has been corrected in the print and online version.
Taylor and Francis apologizes for this error.